| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,873 |
3,963 |
$1.31M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,256 |
9,519 |
$1.11M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
11,516 |
9,471 |
$834K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,140 |
9,032 |
$748K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,326 |
2,175 |
$451K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,351 |
3,183 |
$391K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,173 |
6,610 |
$262K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,726 |
3,564 |
$237K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,848 |
1,732 |
$210K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,331 |
1,671 |
$200K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,526 |
1,443 |
$200K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,677 |
1,570 |
$185K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,266 |
1,101 |
$150K |
| 59025 |
Fetal non-stress test |
1,078 |
623 |
$138K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,818 |
2,454 |
$116K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,136 |
1,090 |
$104K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,696 |
1,530 |
$98K |
| 80053 |
Comprehensive metabolic panel |
16,706 |
14,247 |
$91K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
767 |
309 |
$78K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,647 |
1,400 |
$77K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,116 |
1,065 |
$70K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
785 |
740 |
$64K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,193 |
913 |
$61K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
276 |
181 |
$56K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
258 |
249 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
2,833 |
2,696 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
25,816 |
21,409 |
$48K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,538 |
3,230 |
$39K |
| Q3014 |
Telehealth originating site facility fee |
2,385 |
1,721 |
$38K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,987 |
15,512 |
$35K |
| G0378 |
Hospital observation service, per hour |
1,955 |
1,104 |
$35K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
644 |
636 |
$27K |
| 76830 |
Ultrasound, transvaginal |
900 |
860 |
$25K |
| 84484 |
|
3,773 |
3,308 |
$24K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
325 |
313 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,105 |
3,897 |
$21K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
229 |
219 |
$21K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,341 |
900 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
270 |
250 |
$21K |
| 80050 |
General health panel |
2,289 |
2,230 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,301 |
5,554 |
$20K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
89 |
88 |
$19K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,498 |
3,063 |
$18K |
| 87400 |
|
2,029 |
1,958 |
$17K |
| 80061 |
Lipid panel |
4,190 |
4,049 |
$17K |
| 73630 |
|
830 |
762 |
$17K |
| 73562 |
|
816 |
707 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,313 |
3,195 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,214 |
1,162 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,401 |
4,875 |
$15K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,074 |
1,777 |
$15K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,429 |
4,756 |
$15K |
| 83605 |
|
2,482 |
2,198 |
$15K |
| 84145 |
|
1,402 |
1,243 |
$14K |
| 84439 |
|
2,155 |
2,068 |
$14K |
| 87070 |
|
3,327 |
3,037 |
$14K |
| 97113 |
|
204 |
76 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
3,839 |
3,509 |
$12K |
| 73610 |
|
633 |
576 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,237 |
1,185 |
$12K |
| 87040 |
|
1,247 |
1,092 |
$11K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
68 |
64 |
$11K |
| 97162 |
|
253 |
246 |
$11K |
| 72100 |
|
352 |
343 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
99 |
37 |
$10K |
| 0012A |
|
257 |
251 |
$9K |
| 84702 |
|
1,100 |
885 |
$9K |
| 83880 |
|
1,425 |
1,268 |
$9K |
| 73030 |
|
416 |
375 |
$8K |
| 87077 |
|
3,497 |
3,174 |
$8K |
| 87186 |
|
2,734 |
2,465 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
711 |
579 |
$8K |
| 0011A |
|
279 |
273 |
$7K |
| 97161 |
|
193 |
182 |
$7K |
| 86803 |
|
1,196 |
1,166 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,738 |
1,652 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,064 |
2,327 |
$6K |
| 90837 |
Psychotherapy, 53 minutes with patient |
546 |
302 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
55 |
54 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,691 |
3,829 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
644 |
636 |
$6K |
| 83690 |
|
6,433 |
5,774 |
$6K |
| 73130 |
|
270 |
238 |
$6K |
| 86140 |
|
1,423 |
1,300 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
293 |
281 |
$5K |
| 80305 |
|
2,374 |
2,162 |
$5K |
| 76642 |
|
62 |
52 |
$5K |
| 81025 |
|
4,244 |
3,885 |
$5K |
| 82728 |
|
628 |
603 |
$4K |
| 97116 |
|
344 |
170 |
$4K |
| 85610 |
|
3,883 |
3,379 |
$4K |
| 83735 |
|
2,574 |
2,183 |
$4K |
| 81001 |
|
3,662 |
3,345 |
$4K |
| 84481 |
|
430 |
413 |
$4K |
| 81003 |
|
7,231 |
6,622 |
$4K |
| 73110 |
|
215 |
196 |
$4K |
| 87420 |
|
1,364 |
1,312 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
50 |
42 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
948 |
928 |
$3K |
| 82607 |
|
464 |
447 |
$3K |
| 85379 |
|
518 |
480 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,897 |
4,173 |
$3K |
| 87653 |
|
187 |
182 |
$3K |
| 81002 |
|
1,870 |
1,719 |
$3K |
| 76801 |
|
69 |
64 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,633 |
1,440 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
683 |
661 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
118 |
111 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,584 |
3,903 |
$3K |
| 85651 |
|
1,013 |
954 |
$3K |
| 82550 |
|
3,237 |
2,916 |
$3K |
| 87205 |
|
1,717 |
1,536 |
$3K |
| 83550 |
|
561 |
542 |
$3K |
| 82570 |
|
925 |
845 |
$2K |
| 93971 |
|
25 |
24 |
$2K |
| 82553 |
|
722 |
657 |
$2K |
| 87147 |
|
1,299 |
1,205 |
$2K |
| 0031A |
|
72 |
70 |
$2K |
| 85018 |
|
678 |
645 |
$2K |
| 85730 |
|
2,589 |
2,392 |
$2K |
| 83540 |
|
574 |
554 |
$2K |
| 97010 |
|
145 |
58 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
14 |
12 |
$2K |
| 86900 |
|
1,415 |
1,315 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,199 |
2,135 |
$1K |
| 85014 |
|
370 |
353 |
$1K |
| 85027 |
|
351 |
336 |
$1K |
| 86787 |
|
274 |
266 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
112 |
72 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
32 |
25 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,646 |
2,468 |
$1K |
| 87210 |
|
398 |
349 |
$1K |
| 87634 |
|
59 |
56 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,862 |
2,291 |
$1K |
| 82043 |
|
529 |
499 |
$1K |
| 80055 |
|
201 |
196 |
$1K |
| 86850 |
|
1,190 |
1,127 |
$1K |
| 93017 |
|
14 |
12 |
$942.42 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,246 |
1,885 |
$941.73 |
| 82962 |
|
942 |
673 |
$916.50 |
| 96376 |
|
1,212 |
926 |
$899.71 |
| 74018 |
|
55 |
53 |
$887.75 |
| 86695 |
|
60 |
58 |
$774.54 |
| 86901 |
|
1,414 |
1,315 |
$763.00 |
| 0002A |
|
17 |
17 |
$759.60 |
| 86703 |
|
223 |
206 |
$711.29 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
43 |
42 |
$697.38 |
| J2060 |
Injection, lorazepam, 2 mg |
577 |
382 |
$683.45 |
| 94060 |
|
13 |
13 |
$626.60 |
| C9113 |
Injection, pantoprazole sodium, per vial |
529 |
432 |
$623.29 |
| 90715 |
|
37 |
37 |
$605.75 |
| 73502 |
|
25 |
25 |
$601.48 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
551 |
397 |
$599.33 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
160 |
150 |
$585.91 |
| J2704 |
Injection, propofol, 10 mg |
2,531 |
1,619 |
$560.88 |
| 0001A |
|
15 |
15 |
$520.91 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
37 |
35 |
$453.77 |
| 86696 |
|
60 |
58 |
$376.31 |
| 82950 |
|
98 |
94 |
$330.68 |
| 90832 |
Psychotherapy, 30 minutes with patient |
35 |
26 |
$322.31 |
| 94729 |
|
13 |
13 |
$318.70 |
| 94726 |
|
12 |
12 |
$313.31 |
| 80076 |
|
69 |
64 |
$306.02 |
| G0379 |
Direct admission of patient for hospital observation care |
44 |
38 |
$272.31 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
455 |
337 |
$213.75 |
| 81015 |
|
3,073 |
2,884 |
$202.99 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
40 |
38 |
$195.84 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
292 |
238 |
$167.79 |
| 84403 |
|
25 |
24 |
$163.03 |
| 82105 |
|
15 |
13 |
$131.84 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
226 |
187 |
$106.08 |
| 74022 |
|
30 |
30 |
$104.03 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
18 |
17 |
$95.76 |
| 83001 |
|
12 |
12 |
$82.92 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
13 |
$77.66 |
| 51798 |
|
31 |
27 |
$72.06 |
| 87075 |
|
18 |
16 |
$48.76 |
| 36591 |
|
23 |
14 |
$46.58 |
| 84703 |
|
79 |
77 |
$45.84 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
175 |
135 |
$40.10 |
| 36592 |
|
103 |
48 |
$28.34 |
| 82150 |
|
31 |
29 |
$23.18 |
| J3490 |
Unclassified drugs |
823 |
535 |
$18.97 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
12 |
$13.71 |
| J1940 |
Injection, furosemide, up to 20 mg |
18 |
12 |
$5.41 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
76 |
41 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
15 |
12 |
$0.00 |
| 99152 |
|
17 |
16 |
$0.00 |
| 91300 |
|
17 |
17 |
$0.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
15 |
14 |
$0.00 |
| 85007 |
|
13 |
12 |
$0.00 |
| 96367 |
|
13 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
5,334 |
1,726 |
$0.00 |
| 91303 |
|
69 |
67 |
$0.00 |
| 91301 |
|
532 |
481 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
131 |
119 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
15 |
15 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
19 |
14 |
$0.00 |